Gamma-glutamyl transferase activity increases in prehypertensive patients

To investigate the association between serum gamma-glutamyl transferase (gamma-glutamyl transpeptidase, GGT) levels and prehypertension in a nationally representative sample of Turkish adults. GGT is an enzyme present in serum and most cell surfaces. It is used as an oxidative stress marker. Increased serum GGT levels are implicated in increased blood pressure and the progression of hypertension. GGT may also have a role in the pathogenesis of cardiovascular disease, diabetes mellitus, obstructive sleep apnea syndrome, and metabolic syndrome. Materials and methods: Prehypertension was identified as systolic blood pressure ranging from 120 to 139 mmHg or diastolic blood pressure ranging from 80 to 89 mmHg. Enrolled in this study were 23 female and 45 male patients in the prehypertensive group (Group 1; mean age of 44.6 ± 11.2 years) and 25 female and 43 male patients in the normotensive group (Group 2; mean age of 43.3 ± 7.0 years). The serum GGT activity of these patients was measured. Results: The mean GGT activities were significantly higher in the prehypertension group than in the control group (24.33 and 18.85 U/L, respectively; P < 0.001). Conclusion: Elevated GGT levels in prehypertensive individuals support the idea that these patients are under increased oxidative stress. Even in the prehypertensive stage, it is essential to manage strict cardiovascular risk factor modifications.

Gamma-glutamyl transferase activity increases in prehypertensive patients

To investigate the association between serum gamma-glutamyl transferase (gamma-glutamyl transpeptidase, GGT) levels and prehypertension in a nationally representative sample of Turkish adults. GGT is an enzyme present in serum and most cell surfaces. It is used as an oxidative stress marker. Increased serum GGT levels are implicated in increased blood pressure and the progression of hypertension. GGT may also have a role in the pathogenesis of cardiovascular disease, diabetes mellitus, obstructive sleep apnea syndrome, and metabolic syndrome. Materials and methods: Prehypertension was identified as systolic blood pressure ranging from 120 to 139 mmHg or diastolic blood pressure ranging from 80 to 89 mmHg. Enrolled in this study were 23 female and 45 male patients in the prehypertensive group (Group 1; mean age of 44.6 ± 11.2 years) and 25 female and 43 male patients in the normotensive group (Group 2; mean age of 43.3 ± 7.0 years). The serum GGT activity of these patients was measured. Results: The mean GGT activities were significantly higher in the prehypertension group than in the control group (24.33 and 18.85 U/L, respectively; P < 0.001). Conclusion: Elevated GGT levels in prehypertensive individuals support the idea that these patients are under increased oxidative stress. Even in the prehypertensive stage, it is essential to manage strict cardiovascular risk factor modifications.

___

  • Whitfi eld JB. Gamma-glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
  • Meister A, Tate SS, Ross LL. Membrane bound g-glutamyl transpeptidase. Th e enzymes of biological membranes, Vol. 3. New York: Plenum; 1976. p.315-47.
  • Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma- glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535-9.
  • Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE et al. Gamma glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49: 1358-66.
  • Shankar A, Li J. Association between serum gamma- glutamyltransferase level and prehypertension among US adults. Circ J 2007; 71: 1567-72. 6. Nilssen O, Fİrde OH, Brenn T. Th e Tromsİ Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990; 132: 318-26.
  • Ikai E, Honda R, Yamada Y. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens 1994; 8: 95-100.
  • Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 2006; 27: 2170-6.
  • Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS et al. Gamma-glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk: Th e Framingham Heart Study. Arterioscler Th romb Vasc Biol 2007; 27: 127-33.
  • Barceló A, Barbé F, de la Peña M, Vila M, Pérez G, Piérola J et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006; 27: 756-60.
  • Turgut O, Tandogan I, Gurlek A. Association of gamma- glutamyltransferase with cardiovascular risk: a prognostic outlook. Arch Med Res 2009; 40: 318-20.
  • Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M et al. Th e importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009; 32: 220-5.
  • Caliskan M, Erdogan D, Gullu H, Cift ci O, Yildirim I, Baycan S et al. Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens 2007; 25: 2497-503.
  • Stojakovic T, Scharnagl H, Trauner M, Pieske B, Wellnitz B, Seelhorst U et al. Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography - the Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2010; 208: 564-71.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
  • Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxifi cation. Clin Chim Acta 2003; 333: 19-39.
  • Huseby NE. Multiple forms of serum gamma-glutamyl transferase. Association of the enzyme with lipoproteins. Clin Chim Acta 1982; 124: 103-12.
  • Lee DH, Jacobs DR Jr. Association between serum gammaglutamyl transferase and C-reactive protein. Atherosclerosis 2005; 178: 327-30.
  • Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gammaglutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163 944 Austrian adults. Circulation 2005; 112: 2130-7.
  • Wannamethee G, Ebrahim S, Shaper AG. Gamma- glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142: 699-708.
  • Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A et al. Gamma-glutamyl transpeptidase-dependent iron reduction and low density lipoprotein oxidation: a potential mechanism in atherosclerosis. J Invest Med 1999; 47: 151-60.
  • Emdin M, Passino C, Donato L, Paolicchi A, Pompella A. Serum gammaglutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption. Stroke 2002; 33: 1163-4.
  • Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G et al. Human atherosclerotic plaques contain gamma- glutamyl transpeptidase enzyme activity. Circulation 2004; 109: 1440.
  • Anderson ME, Allison RD, Meister A. Interconversion of leukotrienes catalyzed by purifi ed gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci USA 1982; 79: 1088-91.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

ICSI outcome in severely oligoasthenozoospermic patients and its relationship to prewash progressive sperm motility

Aylin AYRIM, Nilgün TURHAN, Aslıhan PEKEL, Ömer BAYRAK

Histological changes in the healing process of sclerotomy sites aft er 20-gauge and transconjunctival 23- and 25-gauge incisions in experimental model

BARUT Özlem SELVER, Nilüfer KOÇAK, Banu LEBE, Süleyman KAYNAK, Mehmet Özgür ZENGİN

Protective activity of the methanol extract of Usnea longissima against oxidative damage and genotoxicity caused by aflatoxin B1 in vitro

Güleray AĞAR, Ali ASLAN, Elif KOTAN SARIOĞLU, Lokman ALPSOY, Selçuk ÇEKER

ICSI outcome in severely oligoasthenozoospermic patients and its relationship to prewash progressive sperm motility*

Nilgün TURHAN, Aslıhan PEKEL, Aylin AYRIM, Ömer BAYRAK

Documentation of small intestine atresias: a single-institution experience in Turkey (22 cases)

Demet ETİT, Süheyla CUMURCU, Fatma Nur AKTAŞ, Deniz ALTINEL, Rafet BEYHAN, Naciye Ümit BAYOL

Assessment of the left atrial longitudinal myocardial function by Assessment of the left atrial longitudinal myocardial function by the strain and strain rate echocardiography in patients with rheumatic mitral stenosis*

Enbiya AKSAKAL, Serdar SEVİMLİ, Hanefi Yekta GÜRLERTOP, Mehmet Ali ELBEY, Muhammed Hakan TAŞ, Fuat GÜNDOĞDU, Mustafa Kemal EROL, Şule KARAKELLEOĞLU

Long-term outcomes of 23-gauge transconjunctival sutureless vitrectomy

Mehmet ÇITIRIK, Arsen AKINCI, Coşar BATMAN, Tolga BİÇER

Attitudes to the challenges of life among different occupation groups

İrfan ŞENCAN, Olgun GÖKTAŞ, Oğuz TEKİN

Risk factors for smoking behavior among university students

YURT Sevgi ÖNCEL, Ömer Lütfi GEBİZLİOĞLU, ALİEV Fazil ALİOĞLU

Hydatid cyst viability: the effect of scolicidal agents on the scolex in the daughter cyst

Nurdan ÇAY, Mustafa KARAOĞLANOĞLU, Melike Ruşen METİN, Ömer Faruk AKINCI, Hüseyin ÇETİN, Mustafa ULUKANLIGİL